-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-10-18
Values as of: 2019-10-18
The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the John Hancock Dimensional Financials Index. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities that compose the fund's benchmark index. The index is designed to comprise securities in the financials sector within the U.S. Universe whose market capitalizations are larger than that of the 1001st largest U.S. company at the time of reconstitution. The fund is non-diversified.
Company Website : www.jhfunds.com
Currency: USD
Country : USA
Inception Date: 28/09/2015
Primary Benchmark: JH Dimensional Financials TR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 1.19%
Management Expense Ratio: 0.47 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
BANKNIFTY:NSE | 3.96 % | |
ABL | Abacus Life Inc. | 3.74 % |
CVE | Cenovus Energy Inc | 3.39 % |
EMMA | Emmaus Life Sciences Inc | 2.96 % |
CUBI | Customers Bancorp Inc | 2.06 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
SOJE | SOJE | 0.00 % |
-0.42 (-2.11%) |
USD 65.72B |
JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
-0.31 (-0.55%) |
USD 32.43B |
DTB | DTB | 0.00 % |
-0.23 (-1.13%) |
USD 26.58B |
DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
-0.14 (-0.46%) |
USD 26.00B |
GBTC | Grayscale Bitcoin Trust (BTC) | 0.00 % |
+0.70 (+1.23%) |
USD 23.75B |
JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
+0.02 (+0.04%) |
USD 22.73B |
SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.05 (+0.05%) |
USD 19.79B |
AVUV | Avantis® U.S. Small Cap Value.. | 0.00 % |
-0.35 (-0.39%) |
USD 10.49B |
DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
-0.18 (-0.46%) |
USD 10.15B |
DFAT | Dimensional U.S. Targeted Valu.. | 0.00 % |
-0.31 (-0.60%) |
USD 9.40B |
N/A
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 22.63% | 88% | B+ | 76% | C+ | ||
Dividend Return | 1.08% | 36% | F | 23% | F | ||
Total Return | 23.71% | 89% | A- | 74% | C | ||
Trailing 12 Months | |||||||
Capital Gain | 8.49% | 74% | C | 66% | D+ | ||
Dividend Return | 1.83% | 50% | F | 35% | F | ||
Total Return | 10.33% | 74% | C | 63% | D | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | F | ||
Dividend Return | N/A | N/A | N/A | N/A | F | ||
Total Return | N/A | N/A | N/A | N/A | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 10.36% | 91% | A- | 81% | B- | ||
Dividend Return | 11.38% | 91% | A- | 78% | C+ | ||
Total Return | 1.02% | 33% | F | 23% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 14.08% | 32% | F | 56% | F | ||
Risk Adjusted Return | 80.85% | 79% | B- | 80% | B- | ||
Market Capitalization | 0.05B | 38% | F | 16% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.